Lu-177-PSMA-617 approved by FDA for prostate cancer patients Gallery Lu-177-PSMA-617 approved by FDA for prostate cancer patients News Lu-177-PSMA-617 approved by FDA for prostate cancer patients Novartis has obtained US Food and Drug Administration (FDA) marketing [...] Floriane2022-03-29T08:34:34+00:00News| Read More
